US2008153920A1PendingUtilityA1
Fetal physiology during maternal surgery or diagnosis
Est. expiryAug 2, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61K 31/04
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The occurrence of hypercapneic acidosis in a fetus during a laparoscopic procedure carried out on a pregnant female, is prevented or ameliorated by inclusion in or addition to the carbon dioxide insufflation gas, of a nitric oxide donor, e.g., ethyl nitrite. Administration of nitric oxide donor in insufflation gas causes increase in fetal cerebral oxygenation.
Claims
exact text as granted — not AI-modified1 . A method of preventing or ameliorating the presence of hypercapneic acidosis or hypercapnia or acidosis in a fetus of a pregnant female during a laparoscopic procedure carried out on the pregnant female, comprising, in the course of the laparoscopic procedure, administering to said female an insufflating gas comprising carbon dioxide and an amount of a nitric oxide donor effective to prevent or ameliorate the occurrence of hypercapnia and acidosis in the fetus.
2 . The method of claim 1 where the nitric oxide donor is ethyl nitrite.
3 . A method for increasing fetal cerebral oxygenation under conditions of fetal stress, comprising administering to a pregnant female an insufflating gas comprising an amount of nitric oxide donor effective to increase fetal cerebral oxygenation.
4 . The method of claim 3 where the nitric oxide donor is ethyl nitrite.
5 . The method of claim 4 where the ethyl nitrite is present in the insufflating gas in an amount ranging from 1 to 1,000 ppm.
6 . The method of claim 3 where the insufflating gas consists essentially of carbon dioxide and from 1 to 1,000 pm ethyl nitrite.
7 . The method of claim 6 where the insufflating gas consists essentially of carbon dioxide and from 50 to 200 ppm ethyl nitrite.
8 . A method for increasing fetal cerebral oxygenation under conditions of fetal stress comprising administering via inhalation to a female pregnant with the fetus supplemental oxygen and an amount of nitric oxide donor effective to increase fetal cerebral oxygenation.
9 . The method of claim 8 where the nitric oxide donor is ethyl nitrite which is administered at a concentration of 1 to 100 ppm.
10 . A method of preventing or ameliorating the presence of hypercapnia or acidosis or hypercapneic acidosis in a fetus of a pregnant female comprising administering via inhalation to the pregnant female an amount of nitric oxide donor effective to prevent or ameliorate the occurrence of hypercapnia and acidosis in the fetus.
11 . The method of claim 10 where the nitric oxide donor is ethyl nitrite which is administered at a concentration of 1 to 100 ppm.Join the waitlist — get patent alerts
Track US2008153920A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.